PA
ITRN icon

PharVision Advisers’s Ituran Location and Control ITRN Stock Holding History

PharVision Advisers’s Portfolio ITRN Stock Details ITRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,368
Closed -$231K – 378
2025
Q4 		$231K Buy
+5,368
New +$211K 0.12% 442

Other funds holding ITRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Y.D. More Investments
Y.D. More Investments Ramat Gan, Israel $3.21B AUM 117.29% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GW&K Investment Management
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return

PharVision Advisers's ITRN Position: Q1 2026 in Review

PharVision Advisers sold out of Ituran Location and Control (ITRN) in Q1 2026, closing a stake of 5,368 shares — an estimated $231K sold.

PharVision Advisers first reported a position in ITRN in Q4 2025 and held it in 1 quarter. The position peaked at $231K in Q4 2025. 183 funds tracked by Wall St. Rank hold ITRN as of Q1 2026.

  • PharVision Advisers reported no remaining Ituran Location and Control position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 5,368 Ituran Location and Control shares in Q1 2026, an estimated $231K.
  • PharVision Advisers first reported a position in Ituran Location and Control in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Ituran Location and Control position peaked at $231K in Q4 2025.
  • 183 funds tracked by Wall St. Rank held Ituran Location and Control as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.